Skip to content Skip to sidebar Skip to footer
Order Code

6049

Preferred Specimen

Collect 4 mL of clean-catch, midstream urine and transfer it into a urine culture preservative tube (gray-top Boricult®).

Ensure the tube is filled to the marked fill line. Store and transport at room temperature.

Note: For catheterized urine or suprapubic aspirate collections, please order test 6094: Culture, Urine, Catheter.

ContainerType

Urine transport (gray top boricult) tube

Alternate Specimen Requirements

Urine collected in a sterile container, stored refrigerated

Urine collected in preservative systems equivalent to the gray-top Boricult®

Minimum Volume

4 mL urine in transport tube, or
0.5 mL refrigerated urine in sterile urine cup

Transport Temperature

Room temperature

Expected Turnaround Time

4 days

Specimen Stability

Unpreserved urine:

  • Room temperature: Unacceptable
  • Refrigerated: Stable for 24 hours
  • Frozen: Unacceptable

Preserved urine (e.g., Boricult®):

Frozen: Unacceptable

Room temperature: Stable for 48 hours

Refrigerated: Stable for 48 hours

Methodology

Standard urine culture methodology sensitivity is not generally performed on organisms recovered in low number or in mixed urogenital flora

Rejection Criteria

  • Frozen samples
    contaminated samples
    swabs
    unpreserved samples submitted greater than 24 hours
    following collection.
    preserved samples submitted greater than 48 hours
    following collection.
    expired transport media
    non-sterile containers
    samples submitted in leaking containers
    samples submitted in viral transport media
    samples submitted in urinalysis preservative tubes

Overview

Bacterial urinary tract infections (UTIs) are a frequent cause of morbidity and may present with or without symptoms. Common clinical signs include dysuria, abdominal or rectal pain, hematuria, fever, and vomiting.
The organisms most frequently associated with uncomplicated UTIs (Pezzlo, 2014) include:

Gram-Negative Bacteria (prevalence varies by population and setting):

  • Escherichia coli – 70% to 90%
  • Klebsiella pneumoniae – 2% to 6%
  • Proteus mirabilis – 2% to 4%
  • Enterobacter species – 0% to 1%
  • Pseudomonas aeruginosa – 0% to 1%

Gram-Positive Bacteria:

  • Staphylococcus saprophyticus – 5% to 20%
  • Enterococcus species – 1% to 2%
  • Streptococcus agalactiae – 0% to 1%
  • Staphylococcus aureus – 0% to 1%

Fungi:

  • Candida species – 0% to 1%

Urine culture remains the gold standard for diagnosing UTIs. Reliable interpretation depends heavily on collecting a clean, uncontaminated specimen.

Clinical Significance

Isolate and identify potentially pathogenic organisms causing urinary tract infection

Interpretative Information

Urine cultures often yield mixed flora, sometimes involving multiple organisms in varying quantities. To support accurate diagnosis, laboratories follow defined criteria to determine which isolates should be worked up and undergo antimicrobial susceptibility testing (AST). These criteria also help manage testing resources and ensure clinical relevance.

Factors considered by the testing laboratory may include:

Collection method and risk of contamination (e.g., clean-catch vs. catheterized or suprapubic aspirate)

Colony count thresholds for common skin flora versus potential uropathogens

Relative abundance of pathogens versus contaminants

For clean-catch urine, most labs consider ≥10⁴ CFU/mL as the threshold for clinical significance. However, this threshold can vary depending on patient demographics, specimen source, and guidelines followed (e.g., ASM, IDSA, CLSI).

For invasively collected specimens (e.g., catheter or suprapubic aspirate), ≥10³ CFU/mL is often considered significant.

In general, a urine culture is considered clinically relevant when:

The organism is a recognized uropathogen

It is isolated at significant concentrations (typically >10³ or >10⁴ CFU/mL)

No more than two or three uropathogens are present in the culture

Yeast is typically reported descriptively (e.g., “Yeast present”) rather than quantified.

Clinically significant infections typically involve one or two pathogens.

Limitations

  • Forced fluids dilute the urine and may cause reduced colony counts.
  • Cultures of specimens from Foley catheters yield multiple organisms with high colony counts and usually represent colonization of the catheter and not true significant bacteriuria. Foley catheter specimens should not be submitted.
  • Use of urinalysis test results to predict which specimens should be cultured is fraut with problems, not the least of which is the fact that a definition of such a clinically relevant, efficient, and reliable urinalysis result has yet to be determined.
References

Baron EJ, Thomson RB. Specimen collection, transport, and processing: bacteriology. In: Versalovic J, Carroll KC, Funke G, et al, eds. Manual of Clinical Microbiology. 10th ed. Washington, DC: American Society for Microbiology Press; 2011:228-271.

Casey G. Understanding urinary tract infections. Nurs N Z. 2014;20(5):20-23.25144003

Chenoweth CE, Gould CV, Saint S. Diagnosis, management, and prevention of catheter-associated urinary tract infections. Infect Dis Clin North Am. 2014;28(1):105-119.24484578

Dolan VJ, Cornish NE. Urine specimen collection: how a multidisciplinary team improved patient outcomes using best practices. Urol Nurs. 2013;33(5):249-256.24354114

Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103-120.21292654

Kauffman CA. Diagnosis and management of fungal urinary tract infection. Infect Dis Clin North Am. 2014;28(1):61-74.24484575

Kubik MJ, McCarter YS. Controversies in the diagnosis of urinary tract infections. Clin Micro Newslett. 2012;34(23):185-191.

MacFadden DR, Ridgway JP, Robicsek A, Elligsen M, Daneman N. Predictive utility of prior positive urine cultures. Clin Infect Dis. 2014;59(9):1265-1271. 25048850

McCarter YS, Burd EM, Hall GS, Zervos M, Sharp SE, eds. Cumitech 2c: Laboratory Diagnosis of Urinary Tract Infections. Washington, DC: American Society for Microbiology Press; 2009.

Mody L, Juthani-Mehta M. Urinary tract infections in older women: a clinical review. JAMA. 2014;311(8):844-854.24570248

Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005;40(5):643-654. 15714408

Nicolle LE. Catheter associated urinary tract infections. Antimicrob Resist Infect Control. 2014;3:23. 25075308

Nicolle LE. Urinary tract infection. Crit Care Clin. 2013;29(3):699-715.23830659

Pezzlo M. Laboratory diagnosis of urinary tract infections: Guidelines, challenges, and innovations. Clin Micro Newslett. 2013;36(12):87-93.

van Nieuwkoop C, Bonten TN, Wout JW, et al. Risk factors for bacteremia with uropathogen not cultured from urine in adults with febrile urinary tract infection. Clin Infect Dis. 2010;50(11):e69-72.20420504

Alias

  • UA culture
  • Urine culture
Test Setup Days

Daily set up PM shift

CPT

87086 Limited Coverage Test For Medicare.
Advance Beneficiary Notice Of Non-Coverage (ABN) Required
If Diagnosis Is Not Covered.
LOINC: 630-4

Reference Range

NO GROWTH
SMALL QUANTITIES OF UROGENITAL FLORA USUALLY REFLECT
IMPROPER COLLECTION TECHNIQUE

UNIT CODEUNIT CODE NAMEANALYTEGENDERAGEREFERENCE RANGEUnits of Measure
6049URINCULNO GROWTH

Leave a comment

Receive News

Subscribe for the Updates!